By analyzing various quantitative image features extracted from magnetic resonance imaging (MRI) scans using radiomics techniques, researchers have been able to identify potential biomarkers associated with TERT promoter mutations in gliomas. The gene discussed is TERT; the disease is central nervous system cancer.